Enhanced association of probucol with chylomicron by pharmaceutical excipients: an in vitro study

References

• Caliph SM, Faassen WA, Vogel GM, Porter CJ. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues. Curr Drug Deliv 2009;6:359–66
   PubMedGoogle Scholar
• Griffin BT, O’Driscoll CM. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol 2006;58:917–25
   PubMed Web of Science ®Google Scholar
• Holm R, Porter CJ, Müllertz A, et al. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm Res 2002;19:1354–61
   PubMed Web of Science ®Google Scholar
• Porter CJH, Charman SA, Charman WN. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. J Pharm Sci 1996;85:351–6
   PubMed Web of Science ®Google Scholar
• Nielsen PB, Müllertz A, Norling T, Kristensen HG. Comparison of the lymphatic transport of a lipophilic drug from vehicles containing alpha-tocopherol and/or triglycerides in rats. J Pharm Pharmacol 2001;53:1439–45
   PubMed Web of Science ®Google Scholar
• Ling SS, Magosso E, Khan NA, et al. Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm 2006;32:335–45
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 2009;5:184–91
   PubMed Web of Science ®Google Scholar
• Chen Y, Li G, Wu X, et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull 2008;31:118–25
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6:231–48
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, McEvoy CL, McIntosh MP, et al. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524, 515 and CP532, 623). Pharm Res 2010;27:878–93
   PubMed Web of Science ®Google Scholar
• Yáñez JA, Wang SW, Knemeyer IW, et al. Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev 2011;63:923–42
   PubMed Web of Science ®Google Scholar
• Gershkovich P, Hoffman A. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability. Eur J Pharm Sci 2005;26:394–404
   PubMed Web of Science ®Google Scholar
• Charman WN, Stella VJ. Estimating the maximum potential for intestinal lymphatic transport of lipophilic drug molecules. Int J Pharm 1986;34:175–8
   Web of Science ®Google Scholar
• Thakkar H, Nangesh J, Parmar M, Patel D. Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system. J Pharm Bioallied Sci 2011;3:442–8
   PubMedGoogle Scholar
• Memvanga PB, Préat V. Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether. Eur J Pharm Biopharm 2012;82:112–19
   PubMed Web of Science ®Google Scholar
• Sun M, Zhai X, Xue K, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci 2011;43:132–40
   PubMed Web of Science ®Google Scholar
• White KL, Nguyen G, Charman WN, et al. Lymphatic transport of methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU. J Pharmacol Exp Ther 2009;331:700–9
   PubMed Web of Science ®Google Scholar
• Patel PV, Patel HK, Panchal SS, Mehta TA. Self micro-emulsifying drug delivery system of tacrolimus: formulation, in vitro evaluation and stability studies. Int J Pharm Investig 2013;3:95–104
   PubMedGoogle Scholar
• Memvanga PB, Eloy P, Gaigneaux EM, Préat V. In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems. Pharm Res 2013;30:2694–705
   PubMed Web of Science ®Google Scholar
• Apte SP. Selecting surfactants for the maximum inhibition of the activity of the multidrug resistance efflux pump transporter, P-glycoprotein: conceptual development. J Excip Food Chem 2010;3:51–9
   Google Scholar
• Nerurkar MM, Burton PS, Borchardt RT. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res 1996;13:528–34
   PubMed Web of Science ®Google Scholar
• Woodcock DM, Linsenmeyer ME, Chojnowski G, et al. Reversal of multidrug resistance by surfactants. Br J Canc 1992;66:62–8
   PubMed Web of Science ®Google Scholar
• Seeballuck F, Lawless E, Ashford MB, O’Driscoll CM. Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model. Pharm Res 2004;21:2320–6
   PubMed Web of Science ®Google Scholar
• Karpe F, Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 1994;13:1311–17
   Google Scholar
• Hodis HN, Mack WJ, Dunn M, et al. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation 1997;95:2022–6
   PubMed Web of Science ®Google Scholar
• Tondi D, Morandi F, Bonnet R, et al. Structure-based optimization of a non-β-lactam lead results in inhibitors that do not up-regulate β-lactamase expression in cell culture. J Am Chem Soc 2005;127:4632–9
   PubMed Web of Science ®Google Scholar
• Nagananda GS, Satishchandra N. Antimicrobial activity of cold and hot successive pseudobulb extracts of Flickingeria nodosa (Dalz.) Seidenf. Pakistan J Biol Sci 2013;16:1189–93
   PubMedGoogle Scholar
• Zilversmit DB. The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest 1965;44:1610–22
   PubMed Web of Science ®Google Scholar
• Miller KW, Small DM. Surface-to-core and interparticle equilibrium distributions of triglyceride-rich lipoprotein lipids. J Biol Chem 1983;258:13772–84
   PubMed Web of Science ®Google Scholar
• Sparks DL, Lund-Katz S, Phillips MC. The charge and structural stability of apolipoprotein AI in discoidal and spherical recombinant high density lipoprotein particles. J Biol Chem 1992;267:25839–47
   PubMed Web of Science ®Google Scholar
• Guzey D, McClements DJ. Formation, stability and properties of multilayer emulsions for application in the food industry. Adv Colloid Interface Sci 2006;128–30:227–48
   Web of Science ®Google Scholar
• Christensen J, Schultz K, Mollgaard B, et al. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Pharm Sci 2004;23:287–96
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 2008;60:702–16
   PubMed Web of Science ®Google Scholar